Biomarker-directed combination effective in immunotherapy-resistant lung cancer

Reverse metabolomics: New method finds biomarker for inflammatory bowel disease

Scientists engineer potent immune cells for 'off-the-shelf' cancer immunotherapy

Lung cancer outcomes significantly improved with immunotherapy-based treatment given before and after surgery